All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2008-005234-79 | Safety and efficacy of fondaparinux 1.5 mg in the prevention of venous thromboembolism in medical patients with severe renal insufficiency | 2012-01-31 | due-trials |
Ongoing | 2014-005162-29 | Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study Officiële titel: Behandeling van portale, mesenterische en splenische veneuze tro... | not-yet-due | |
Not reported | 2016-000958-36 | RIDTS Study - Rivaroxaban for the treatment of symptomatic Isolated Distal deep vein Thrombosis “RIVAROXABAN PER 6 O PER 12 SETTIMANE NEL TRATTAMENTO DELLE TROMBOSI VENOSE PROFONDE DISTALI ISOLATE ... | 2022-03-01 | due-trials |